BioCentury
ARTICLE | Finance

A little less lumpy

Why Atlas added Amgen, Novartis as LPs in Fund IX

May 20, 2013 7:00 AM UTC

Atlas Venture recruited Amgen Inc. and Novartis AG as more than just new LPs in its ninth fund - the VC hopes closer ties with the companies will deliver useful feedback on potential startups and additional sources for collaboration.

Atlas closed the fund this month, raising $265 million that will primarily go towards seeding biotech and technology startups (see BioCentury, May 6)...